Intra-Cellular Therapies, Inc. (ITCI)
NASDAQ: ITCI · Real-Time Price · USD
131.94
+0.13 (0.10%)
Mar 31, 2025, 10:07 AM EDT - Market open
Intra-Cellular Therapies Employees
Intra-Cellular Therapies had 860 employees as of December 31, 2024. The number of employees increased by 250 or 40.98% compared to the previous year.
Employees
860
Change (1Y)
250
Growth (1Y)
40.98%
Revenue / Employee
$791,688
Profits / Employee
-$86,833
Market Cap
14.03B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 860 | 250 | 40.98% |
Dec 31, 2023 | 610 | 49 | 8.73% |
Dec 31, 2022 | 561 | 49 | 9.57% |
Dec 31, 2021 | 512 | 129 | 33.68% |
Dec 31, 2020 | 383 | 53 | 16.06% |
Dec 31, 2019 | 330 | 257 | 352.05% |
Dec 31, 2018 | 73 | 24 | 48.98% |
Dec 31, 2017 | 49 | 7 | 16.67% |
Dec 31, 2016 | 42 | 3 | 7.69% |
Dec 31, 2015 | 39 | 13 | 50.00% |
Dec 31, 2014 | 26 | 4 | 18.18% |
Mar 31, 2013 | 22 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ITCI News
- 4 weeks ago - INTRA-CELLULAR THERAPIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intra-Cellular Therapies, Inc. - ITCI - Business Wire
- 5 weeks ago - Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last? - CNBC
- 2 months ago - Top 4 Health Care Stocks You May Want To Dump In Q1 - Benzinga
- 2 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN and ITCI on Behalf of Shareholders - PRNewsWire
- 2 months ago - Johnson & Johnson to Acquire Intra-Cellular in $15 Billion Deal - WSJ
- 2 months ago - Drugmakers rush to sign deals on first day of industry conference - Reuters
- 2 months ago - Like Bristol-Myers Squibb And AbbVie, Johnson & Johnson Seeks To Bolster Neuropsychiatric Portfolio With $15 Billion Deal - Benzinga